Company profile: Scienion
1.1 - Company Overview
Company description
- Provider of ultra-low volume liquid handling systems and microarray technologies enabling multiparallel bioanalytics, high throughput screening, and high throughput microarray production in genomics. Offerings include automated dispensers (sciFLEXARRAYER), pico- to microliter non-contact printing (sciDROP PICO), single-cell isolation (CellenONE), functionalized slides (sciCHIPs), buffers (sciBUFFERs), and consumables.
Products and services
- SciCHIPs: Surface-functionalized glass slides that attach biomolecules, enabling development and production of DNA, protein, and glycan microarrays for high-throughput microarray manufacturing
- SciDROP PICO: High-precision, non-contact dispensing technology handling pico- to microliter volumes, used for non-contact printing of capture molecules onto surfaces
- SciFLEXARRAYER: Automated ultra-low-volume liquid dispensing systems engineered for precise handling, used in microarray printing and biosensor production.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Scienion
ARTMS
HQ: Canada
Website
- Description: Provider of cyclotron-based technology for decentralized, local production of diagnostic imaging isotopes and purified radiopharmaceuticals. Offers the QUANTM Irradiation System (QIS) and QUANTM platforms for gallium-68, technetium-99m, zirconium-89, and copper-64, featuring automatic 2-way pneumatic transfer, a compact solid target station, and complete solid target processing solutions for PET and other clinical applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ARTMS company profile →
Rheonix
HQ: United States
Website
- Description: Provider of automated molecular testing solutions featuring interchangeable purification, amplification and detection, including Encompass MDx and Encompass Optimum workstations for DNA/RNA extraction and high multiplexing in food and beverage industries, and assays for SARS-CoV-2 (saliva/respiratory), Listeria PatternAlert, Beer SpoilerAlert, and Cyclospora cayetanensis in produce.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rheonix company profile →
BIA Separations
HQ: Slovenia
Website
- Description: Provider of proprietary monolithic chromatography columns based on CIM Convective Interaction Media technology for production, purification, and analysis of large biomolecules, including viruses, plasmid DNA, exosomes, antibodies, bacteriophages, and large proteins. Offers CIMmultus preparative and CIMac analytical columns, PATfix analytical standards, and Cornerstone services and process development support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BIA Separations company profile →
Helmer Scientific
HQ: United States
Website
- Description: Provider of specialized medical and laboratory equipment, including GX Solutions medical-grade refrigerators and freezers for critical healthcare applications with temperature control, noise management, and energy efficiency; Pro Line platelet incubators with performance monitoring and advanced cooling; i.Series ultra-low temperature freezers; i.Series laboratory refrigerators/freezers; and blood bank refrigerators.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Helmer Scientific company profile →
Emulate
HQ: United States
Website
- Description: Provider of advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Emulate company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Scienion
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Scienion
2.2 - Growth funds investing in similar companies to Scienion
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Scienion
4.2 - Public trading comparable groups for Scienion
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →